02 November 2016
Bird & Bird Paris welcomes Emmanuelle Porte as a partner in the Life Sciences Corporate group
www.twobirds.com/en/news/press-releases/2016/france/bird-and-bird-paris-welcomes-emmanuelle-porte-as-a-partner-in-the-life-sciences-corporate-group

03 December 2018
Bird & Bird boosts its Corporate practice with the appointment of Life Sciences expert Michiel Wurfbain as a partner in The Hague
www.twobirds.com/en/news/press-releases/2018/netherlands/bird-and-bird-boosts-its-corporate-practice-with-the-appointment-of-michiel-wurfbain-as-a-partner

International law firm Bird & Bird today boosts its Corporate practice with the appointment of life sciences expert Michiel Wurfbain as a partner in The Hague.

18 January 2021
Bird & Bird advises Pfizer on global spin-off
www.twobirds.com/en/news/press-releases/2021/germany/bird-and-bird-advises-pfizer-on-global-spin-off

Bird & Bird LLP has advised Pfizer on the global spin-off and merger of its Upjohn business with Mylan N.V. to form the new global pharmaceutical company with the name Viatris Inc.

22 July 2020
Bird & Bird advises InGeneron on divestment of Eticur GmbH
www.twobirds.com/en/news/press-releases/2020/global/bird-and-bird-advises-ingeneron-on-divestment-of-eticur-gmbh

Bird & Bird LLP has advised the US company InGeneron on the sale of 100% of the shares in the Munich-based private umbilical cord blood banking company Eticur GmbH to Polski Bank Komórek Macierzystych.

05 April 2019
Bird & Bird advises Serum Institute of India Pvt. Ltd. on the acquisition of the majority share in Vakzine Projekt Management GmbH
www.twobirds.com/en/news/press-releases/2019/germany/bird-and-bird-advises-serum-institute-of-india-pvt-ltd-on-the

International law firm Bird & Bird advises Indian vaccine manufacturer Serum Institute of India Pvt. Ltd. on the acquisition of the majority share in German project management service provider Vakzine Projekt Management ...

01 June 2020
Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB
www.twobirds.com/en/news/press-releases/2020/czech-republic/bird-and-bird-law-firm-advised-indian-vaccine-manufacturer-serum-institute-of-india-pvt-ltd

Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB, subsidiary of Novavax Inc, US ...

24 May 2019
Bird & Bird advises FUJIFILM on the 100% acquisition of medwork
www.twobirds.com/en/news/press-releases/2019/germany/bird-and-bird-advises-fujifilm-on-the-100-acquisition-of-medwork

International law firm Bird & Bird advises the FUJIFILM group on the acquisition of German medwork GmbH, a company that develops, manufactures and markets instruments for therapeutic and diagnostic endoscopy

24 April 2020
Bird & Bird team shortlisted in multiple categories for the 8th annual LMG Life Sciences Awards 2020 Europe
www.twobirds.com/en/news/press-releases/2020/global/bird-and-bird-team-shortlisted-in-multiple-categories-for-the-8th-annual-lmg-life-sciences-awards

Our international Life Sciences & Healthcare Group is extremely proud to have been recognised among individuals and companies behind the most innovative and challenging Life Sciences work of the past year, as well as ...

30 May 2019
International team advises Chiesi Farmaceutici on in-licence of Raxone® from Santhera
www.twobirds.com/en/news/press-releases/2019/uk/international-team-advises-chiesi-farmaceutici-on-inlicence-of-raxone-from-santhera

International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")

28 February 2020
Bird & Bird advises Mitsubishi Chemical Corporation on the acquisition of c-m-p
www.twobirds.com/en/news/press-releases/2020/germany/bird-beraet-mitsubishi-chemical-corporation

International law firm Bird & Bird advises Mitsubishi Chemical Advanced Materials (MCAM), a leading global manufacturer of high-performance materials and a business division of Mitsubishi Chemical Corporation, Japan, on ...